SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001140361-22-042317
Filing Date
2022-11-18
Accepted
2022-11-18 16:17:11
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 6-K/A brhc100441106ka.htm 6-K/A 18264
2 EXHIBIT 99.1 brhc10044110_ex99-1.htm   iXBRL EX-99.1 780469
  Complete submission text file 0001140361-22-042317.txt   3845560

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE imcr-20220930.xsd EX-101.SCH 42145
4 XBRL CALCULATION FILE imcr-20220930_cal.xml EX-101.CAL 50833
5 XBRL DEFINITION FILE imcr-20220930_def.xml EX-101.DEF 127321
6 XBRL LABEL FILE imcr-20220930_lab.xml EX-101.LAB 418789
7 XBRL PRESENTATION FILE imcr-20220930_pre.xml EX-101.PRE 245220
52 EXTRACTED XBRL INSTANCE DOCUMENT brhc10044110_ex99-1_htm.xml XML 544471
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-39992 | Film No.: 221402151
SIC: 2836 Biological Products, (No Diagnostic Substances)